<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Gilead Sciences, Inc. - Google Finance</title>
<description>News for Gilead Sciences, Inc. - Google Finance</description>
<link>http://www.google.ca/finance?q=NASDAQ:GILD&amp;amp;client=news-rss&amp;amp;ei=FdmZUZCpNqKkiQKECQ</link>
<image>
<title>News for Gilead Sciences, Inc. - Google Finance</title>
<url>/finance/s/HeRQIg9C9Us/images/logo_ca.gif</url>
<link>http://www.google.ca/finance?q=NASDAQ:GILD&amp;amp;client=news-rss&amp;amp;ei=FdmZUZCpNqKkiQKECQ</link>
</image>
<item>
<title>GILEAD SCIENCES, INC. : Gilead Sciences to Present at the 2013 UBS Global ...</title>
<link>http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Sciences-to-Present-at-the-2013-UBS-Global-Healthcare-Conference-on-M-16870659/</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:43982064281847</guid>
<pubDate>Fri, 17 May 2013 20:11:35 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Sciences-to-Present-at-the-2013-UBS-Global-Healthcare-Conference-on-M-16870659/&quot; style=&quot;font-size:1.2em&quot;&gt;GILEAD SCIENCES, INC. : Gilead Sciences to Present at the 2013 UBS Global ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 2013 UBS Global Healthcare Conference in New York.&lt;/div&gt;
&lt;a href=&quot;http://utahpeoplespost.com/2013/05/gilead-sciences-pt-raised-to-67-00-at-ubs-ag-gild/&quot;&gt;Gilead Sciences PT Raised to $67.00 at UBS AG (GILD)&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;The Utah People&#39;s Post&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GILEAD SCIENCES, INC. : Gilead Announces Response Data from Phase 2 ...</title>
<link>http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Announces-Response-Data-from-Phase-2-Study-of-Idelalisib-for-Previous-16865405/</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Announces-Response-Data-from-Phase-2-Study-of-Idelalisib-for-Previous-16865405/</guid>
<pubDate>Wed, 15 May 2013 22:36:38 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Announces-Response-Data-from-Phase-2-Study-of-Idelalisib-for-Previous-16865405/&quot; style=&quot;font-size:1.2em&quot;&gt;GILEAD SCIENCES, INC. : Gilead Announces Response Data from Phase 2 ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta, in combination with rituximab for older patients with ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Theravance Inc. (NASDAQ:THRX), Gilead Sciences Inc. (NASDAQ:GILD), and ...</title>
<link>http://www.sbwire.com/press-releases/theravance-inc-nasdaqthrx-gilead-sciences-inc-nasdaqgild-and-unilife-corporation-nasdaqunis-added-to-equity-profile-reports-nasdaq-gainers-watch-list-251257.htm</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:43982060517752</guid>
<pubDate>Mon, 13 May 2013 18:57:47 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/theravance-inc-nasdaqthrx-gilead-sciences-inc-nasdaqgild-and-unilife-corporation-nasdaqunis-added-to-equity-profile-reports-nasdaq-gainers-watch-list-251257.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Theravance Inc. (NASDAQ:THRX), Gilead Sciences Inc. (NASDAQ:GILD), and ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia is currently up (+2.94%) on 10,887,989 ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Reveal Insider Trading in JC Penney, Gilead Sciences, Chesapeake Energy ...</title>
<link>http://www.marketwatch.com/story/reveal-insider-trading-in-jc-penney-gilead-sciences-chesapeake-energy-annaly-capital-management-endo-health-solutions-and-zynga-2013-05-14</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:43982061344272</guid>
<pubDate>Tue, 14 May 2013 12:55:57 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.marketwatch.com/story/reveal-insider-trading-in-jc-penney-gilead-sciences-chesapeake-energy-annaly-capital-management-endo-health-solutions-and-zynga-2013-05-14&quot; style=&quot;font-size:1.2em&quot;&gt;Reveal Insider Trading in JC Penney, Gilead Sciences, Chesapeake Energy ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MarketWatch (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Gilead Sciences, Inc. (NASDAQ:GILD) : By the end of last trading session, Gilead Sciences (NASDAQ:GILD) shares earned US$1.59 (or 3.01%) to US$54.47 with about 14.49 million shares exchanged hands for the session, compared to its average volume of ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Gilead Sciences To Present At Bank Of America Conference;Webcast At 12:20 ...</title>
<link>http://www.nasdaq.com/article/gilead-sciences-to-present-at-bank-of-america-conferencewebcast-at-1220-pm-et-20130515-00881</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:http://www.nasdaq.com/article/gilead-sciences-to-present-at-bank-of-america-conferencewebcast-at-1220-pm-et-20130515-00881</guid>
<pubDate>Wed, 15 May 2013 15:27:26 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/gilead-sciences-to-present-at-bank-of-america-conferencewebcast-at-1220-pm-et-20130515-00881&quot; style=&quot;font-size:1.2em&quot;&gt;Gilead Sciences To Present At Bank Of America Conference;Webcast At 12:20 ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;NASDAQ&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(RTTNews.com) - Gilead Sciences Inc. ( GILD ) will present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Gilead Sciences, Inc. (GILD) Call Traders Target New Highs</title>
<link>http://www.schaeffersresearch.com/marketcenters/optionscenter/content/gilead+sciences+inc+gild+call+traders+target+new+highs/default.aspx?ID=116070</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:http://www.schaeffersresearch.com/marketcenters/optionscenter/content/gilead+sciences+inc+gild+call+traders+target+new+highs/default.aspx?ID=116070</guid>
<pubDate>Tue, 14 May 2013 13:20:34 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.schaeffersresearch.com/marketcenters/optionscenter/content/gilead+sciences+inc+gild+call+traders+target+new+highs/default.aspx?ID=116070&quot; style=&quot;font-size:1.2em&quot;&gt;Gilead Sciences, Inc. (GILD) Call Traders Target New Highs&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Schaeffers Research&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Calls were the options of choice on Gilead Sciences, Inc. (NASDAQ:GILD) yesterday, with roughly 27,000 contracts crossing the tape during the course of the session.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Is Gilead Sciences, Inc. (GILD) Still A Buy?</title>
<link>http://www.insidermonkey.com/blog/is-gilead-sciences-inc-gild-still-a-buy-141499/</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:http://www.insidermonkey.com/blog/is-gilead-sciences-inc-gild-still-a-buy-141499/</guid>
<pubDate>Tue, 14 May 2013 19:24:45 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/is-gilead-sciences-inc-gild-still-a-buy-141499/&quot; style=&quot;font-size:1.2em&quot;&gt;Is Gilead Sciences, Inc. (GILD) Still A Buy?&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2. The biotech announced earnings of $0.48 per share while analysts were expecting $0.50 per share.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Gilead Sciences climbs to all-time highs</title>
<link>http://www.businessweek.com/ap/2013-05-03/gilead-sciences-climbs-to-all-time-highs</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:52778141513549</guid>
<pubDate>Fri, 03 May 2013 21:05:27 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.businessweek.com/ap/2013-05-03/gilead-sciences-climbs-to-all-time-highs&quot; style=&quot;font-size:1.2em&quot;&gt;Gilead Sciences climbs to all-time highs&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Businessweek&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 3, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;NEW YORK (AP) - Shares of Gilead Sciences Inc. rose to all-time highs Friday after the company reported its first-quarter results and new trial data for two of its experimental hepatitis C drugs.&lt;/div&gt;
&lt;a href=&quot;http://www.rttnews.com/2109521/gilead-sciences-inc-gild-has-climbed-to-a-new-high-on-q1-results.aspx?type=sta&quot;&gt;Gilead Sciences Inc. (GILD) Has Climbed To A New High On Q1 Results&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;RTT News&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://blogs.marketwatch.com/health-exchange/2013/05/03/fda-letter-earnings-disappointment-dont-slow-down-gilead-shares/&quot;&gt;FDA letter, earnings disappointment don&amp;#39;t slow down Gilead shares&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;MarketWatch (blog)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Gilead Sciences Inc. (NASDAQ:GILD), Express Scripts Holding Company ...</title>
<link>http://www.sbwire.com/press-releases/gilead-sciences-inc-nasdaqgild-express-scripts-holding-company-nasdaqesrx-and-life-technologies-corporation-nasdaqlife-added-to-growing-stock-reports-nasdaq-decliners-watch-list-247921.htm</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:52778146989378</guid>
<pubDate>Tue, 07 May 2013 13:04:01 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/gilead-sciences-inc-nasdaqgild-express-scripts-holding-company-nasdaqesrx-and-life-technologies-corporation-nasdaqlife-added-to-growing-stock-reports-nasdaq-decliners-watch-list-247921.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Gilead Sciences Inc. (NASDAQ:GILD), Express Scripts Holding Company ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 7, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Gilead Sciences Inc. (NASDAQ:GILD), Express Scripts Holding Company (NASDAQ:ESRX), and Life Technologies Corporation ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GILEAD SCIENCES, INC. : Gilead Sciences to Release First Quarter 2013 ...</title>
<link>http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Sciences-to-Release-First-Quarter-2013-Financial-Results-on-Thursday-16776946/</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:52778131845902</guid>
<pubDate>Thu, 25 Apr 2013 20:39:31 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Inc-Gilead-Sciences-to-Release-First-Quarter-2013-Financial-Results-on-Thursday-16776946/&quot; style=&quot;font-size:1.2em&quot;&gt;GILEAD SCIENCES, INC. : Gilead Sciences to Release First Quarter 2013 ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2013 financial results will be released on Thursday, May 2, at 4:05 p.m.&lt;/div&gt;
&lt;a href=&quot;http://www.twst.com/news/956-gilead-sciences-inc-gild-leading-the-charge-in-hepatitis-c-s&quot;&gt;Gilead Sciences, Inc. (GILD) Leading the Charge in Hepatitis C Space with ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;The Wall Street Transcript (blog)&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.meshpress.com/stocks-in-news-homeaway-synergy-pharmaceuticals-inc-iamgold-corporation-gilead-sciences/1235702.html&quot;&gt;Stocks In News (HomeAway, Synergy Pharmaceuticals Inc, IAMGOLD ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Mesh Press (press release)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
